Hong Kong, China

Haiqin Deng

This inventor holds 2 USPTO granted patents. Top assignee: The Hong Kong University of Science and Technology. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haiqin Deng. Retrieved from https://idiyas.com/inventor/haiqin-deng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.8

ph-index = 1


Company Filing History:


Years Active: 2016-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Haiqin Deng in Cancer Treatment

Introduction

Haiqin Deng is a prominent inventor based in Hong Kong, CN. She has made significant contributions to the field of cancer treatment through her innovative research and development of AIE luminogens. With a total of 2 patents, her work focuses on enhancing the visualization and treatment of cancer cells.

Latest Patents

Haiqin Deng's latest patents include groundbreaking advancements in AIE luminogens for cancer visualization and treatment. One of her notable inventions involves AIE luminogenic probes designed for cancer cell visualization and discrimination. These probes target lysosomes for imaging and autophagy visualization, and they serve as highly fluorescent AIE-active theranostic agents. They are capable of monitoring drug distribution and exhibiting anti-tumor activity against specific cancer cells. Additionally, her work includes methods for preparing AIE luminogens that possess clusteroluminogenic features and applications.

Another significant patent focuses on photostable AIE luminogens for specific mitochondrial imaging. This invention includes AIE-active TPE derivatives such as TPE-TPP, TPE-MitoR, and TPE-IQ. These derivatives are designed as fluorescent agents for mitochondrial imaging and as apoptosis inducers. They exhibit high specificity to mitochondria, superior photostability, and appreciable tolerance to changes in the microenvironment. The synthetic flexibility of these TPE derivatives allows for further modifications, enabling their use as dual-functional probes for various applications, including sensing of ROS, metal ions, or pH changes in mitochondria.

Career Highlights

Haiqin Deng is affiliated with The Hong Kong University of Science and Technology, where she continues to advance her research in the field of cancer treatment. Her innovative work has positioned her as a leading figure in the development of AIE luminogens.

Collaborations

Some of her notable coworkers include Benzhong Tang and Engui Zhao, who have collaborated with her on various research projects.

Conclusion

Haiqin Deng's contributions to cancer treatment through her innovative patents highlight her expertise and dedication to advancing medical science. Her work with AIE luminogens represents a significant step forward in the visualization and treatment of cancer, showcasing the potential of her inventions in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…